NovoCure Ltd. (NVCR) PT Raised to $24 at H.C. Wainwright

July 26, 2024 6:48 AM

H.C. Wainwright analyst Emily Bodnar raised the price target on NovoCure Ltd. (NASDAQ: NVCR) to $24.00 (from $22.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found